FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Actavis Dextroamphetamine Sulfate Extended-Release Recall

Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg, 90- count bottles, Rx Only…

Actavis Inc · Parsippany, NJ

Risk level
Class II
Reported by FDA
Aug 3, 2016
Recall ID
D-1448-2016
Check your lot numberHow we source this data

Summary

Actavis recalled Dextroamphetamine Sulfate Extended-Release starting Jul 11, 2016. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1448-2016 on Aug 3, 2016. Reason: Failed Dissolution Specifications. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications

Product description

Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg, 90- count bottles, Rx Only Manufactured by: Actavis Elizabeth LLC Elizabeth, NJ 07207 USA; Distributed by: Actavis Pharma, Inc Parsippany, NJ 07054 USA NDC 45963-304-09

Lot numbers, UPCs & expiration codes

Lot #: 3803J141, Exp. 7/2016

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1448-2016
Classification
Class II
Status
Terminated
Recall initiated
Jul 11, 2016
FDA report date
Aug 3, 2016
Quantity
8,062 units
Recall type
Voluntary: Firm initiated
Recalling firm
Actavis Inc

Original FDA data

Every field from FDA enforcement report D-1448-2016, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Terminated
Country
United States
Event ID
74713
Address
400 Interpace Pkwy
Code information
Lot #: 3803J141, Exp. 7/2016
Postal code
07054-1120
Report date
Aug 3, 2016
Product type
Drugs
Recall number
D-1448-2016
Classification
Class II
Recalling firm
Actavis Inc
Product quantity
8,062 units
Termination date
Feb 16, 2017
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg, 90- count bottles, Rx Only Manufactured by: Actavis Elizabeth LLC Elizabeth, NJ 07207 USA; Distributed by: Actavis Pharma, Inc Parsippany, NJ 07054 USA NDC 45963-304-09
Distribution pattern
Nationwide
Recall initiation date
Jul 11, 2016
Initial firm notification
Letter
Center classification date
Jul 26, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1448-2016, published Aug 3, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls